December 12th, 2024

Pharmacare would cost public sector billions more a year, but save economy money: PBO

By Nojoud Al Mallees, The Canadian Press on October 12, 2023.

Parliamentary Budget Officer Yves Giroux waits to appear before appearing at the Senate Committee on National Finance, Tuesday, October 25, 2022 in Ottawa. The parliamentary budget officer says a single-payer universal drug plan would cost the federal and provincial governments an additional $11.2 billion in the first year, and $13.4 billion in five years. THE CANADIAN PRESS/Adrian Wyld

OTTAWA – The parliamentary budget officer says a single-payer universal drug plan would cost federal and provincial governments $11.2 billion in the first year, and $13.4 billion in five years.

The PBO’s report, released on Thursday, provides an estimate for the cost of a pharmacare program between 2024-25 and 2027-28.

It calculates the incremental cost of the program, taking into account current spending by governments on public drug plans as well as revenue that would be generated from co-pays under a pharmacare plan.

The Liberals have promised to table pharmacare legislation this fall as part of the supply-and-confidence deal the government struck with the NDP.

The report finds that a single-payer universal drug plan would lead to economy-wide savings, despite the fact it estimates that the use of prescription drugs would rise by 13.5 per cent.

That’s because the report assumes that the implementation of a single-payer universal plan would allow for better price negotiations, leading to lower drug prices.

The PBO estimates cost savings on drug expenditures of $1.4 billion in 2024-25, with that figure increasing to $2.2 billion by 2027-28.

The report also looks at alternative coverage plans, as the federal government continues to work on what form a pharmacare program could take.

A plan that only covers catastrophic medicines, a term used to describe expensive drugs that could cause financial hardship, would cost governments an additional $400 million in the first year and $2 billion in five years.

Meanwhile, a plan that covers only essential medicines, which refers to medicines that address the priority health-care needs of a population, would cost an additional $2.4 billion in the first year and $12.1 billion in five years.

This report by The Canadian Press was first published Oct. 12, 2023.

Share this story:

12
-11

Comments are closed.